[1] REFARDT J, WINZELER B, CHRIST-CRAIN M. Copeptin and its role in the diagnosis of diabetes insipidus and the syndrome of inappropriate antidiuresis[J]. Clin Endocrinol, 2019, 91(1): 22. doi: 10.1111/cen.13991
[2] HARROIS A, ANSTEY JR. Diabetes Insipidus and syndrome of inappropriate antidiuretic hormone in critically ill patients[J]. Crit Care Clin, 2019, 35(2): 187. doi: 10.1016/j.ccc.2018.11.001
[3] KLAASSEN I, VAN NOORDEN CJ, SCHLINGEMANN RO. Molecular basis of the inner blood-retinal barrier and its breakdown in diabetic macular edema and other pathological conditions[J]. Prog Retin Eye Res, 2013, 34: 19. doi: 10.1016/j.preteyeres.2013.02.001
[4] MILLER K, FORTUN JA. Diabetic macular edema: current understanding, pharmacologic treatment options, and developing therapies[J]. Asia Pac J Ophthalmol, 2018, 7(1): 28.
[5] 赵宏锟, 邹悦, 李云琴. 阈下微脉冲激光在眼科疾病治疗中的应用[J]. 国际眼科杂志, 2020, 20(1): 4.
[6] 孙光丽, 姜静, 王成虎, 等. 高密度微脉冲激光联合玻璃体内注射雷珠单抗治疗糖尿病性黄斑水肿[J]. 眼科新进展, 2017, 37(3): 3.
[7] JIA Y, TAN O, TOKAYER J, et al. Split-spectrum amplitude-decorrelation angiography with optical coherence tomography[J]. Opt Express, 2012, 20(4): 4710. doi: 10.1364/OE.20.004710
[8] LI X, XU G, WANG Y, et al. AURORA Study Group. Safety and efficacy of conbercept in neovascular age-related macular degeneration: results from a 12-month randomized phase 2 study: AURORA study[J]. Ophthalmology, 2014, 121(9): 1740. doi: 10.1016/j.ophtha.2014.03.026
[9] ZHAO N, GUAN J, CAI N, et al. Efficacy of intravitreal conbercept combined with panretinal photocoagulation for severe nonproliferative diabetic retinopathy without macular edema[J]. Int J Ophthalmol, 2022, 15(4): 615. doi: 10.18240/ijo.2022.04.15
[10] BUCOLO C, GOZZO L, LONGO L, et al. Long-term efficacy and safety profile of multiple injections of intravitreal dexamethasone implant to manage diabetic macular edema: a systematic review of real-world studies[J]. J Pharmacol, 2018, 138(4): 219.
[11] KOUSHAN K, ESHTIAGHI A, FUNG P, et al. Treatment of diabetic macular edema with aflibercept and micropulse laser (DAM Study)[J]. Clin Ophthalmol, 2022, 16: 1109. doi: 10.2147/OPTH.S360869
[12] MOISSEIEV E, ABBASSI S, THINDA S, et al. Subthreshold micropulse laser reduces anti-VEGF injection burden in patients with diabetic macular edema[J]. Eur J Ophthalmol, 2018, 28(1): 68. doi: 10.5301/ejo.5001000
[13] MIDENA E, BINI S, MARTINI F, et al. Changes of aqueous humor muller cells biomarkers in human patients affected by diabetic macular edema after subthreshold micropulse laser treatment[J]. Retina, 2020, 40(1): 126. doi: 10.1097/IAE.0000000000002356
[14] LALLY DR, SHAH CP, HEIER JS. Vascular endothelial growth factor and diabetic macular edema[J]. Surv Ophthalmol, 2016, 61(6): 759. doi: 10.1016/j.survophthal.2016.03.010
[15] 陈丽华, 莫纯坚. 抗VEGF药物治疗糖尿病黄斑水肿的临床应用[J]. 东南国防医药, 2015, 17(4): 4.
[16] ALTINEL MG, ACIKALIN B, ALIS MG, et al. Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema[J]. Lasers Med, 2021, 36(7): 1545. doi: 10.1007/s10103-021-03306-0
[17] 张祺, 段淯平, 金中秋. 阿柏西普联合阈值下微脉冲激光治疗糖尿病黄斑水肿30例[J]. 医药导报, 2021, 40(5): 631.
[18] 向湘, 马红婕, 唐仕波. OCTA在DR患者黄斑血流密度观察中的应用[J]. 国际眼科杂志, 2017, 17(7): 1344.
[19] KIM AY, CHU Z, SHAHIDZADEH A, et al. Quantifying microvascular density and morphology in diabetic retinopathy using spectral-domain optical coherence tomography angiography[J]. Invest Ophthalmol Vis Sci, 2016, 57(9): 362. doi: 10.1167/iovs.15-18904
[20] SUZUKI N, HIRANO Y, TOMIYASU T, et al. Retinal hemodynamics seen on optical coherence tomography angiography before and after treatment of retinal vein occlusion[J]. Invest Ophthalmol, 2016, 57(13): 5681. doi: 10.1167/iovs-16-20648
[21] TAN PE, YU PK, BALARATNASINGAM C, et al. Quantitative confocal imaging of the retinal microvasculature in the human retina[J]. Invest Ophthalmol, 2012, 53(9): 5728.
[22] VUJOSEVIC S, GATTI V, MURACA A, et al. Optical coherence tomography omography angiography changes after subthreshold micropulse yellow laser in diabetic macular edema[J]. Retina, 2020, 40(2): 312.
[23] ALTINEL MG, ACIKALIN B, ALIS MG, et al. Comparison of the efficacy and safety of anti-VEGF monotherapy versus anti-VEGF therapy combined with subthreshold micropulse laser therapy for diabetic macular edema[J]. Lasers Med, 2021, 36(7): 1545.
[24] 赵宏锟, 邹悦, 李云琴. 阈下微脉冲激光在眼科疾病治疗中的应用[J]. 国际眼科杂志, 2020, 20(1): 4.